Assessment and workup for delirium
- the most important step in evaluating suspected delirium is obtaining a collateral history from someone who knows the patient well (for example family member or caregiver) and performing a structured clinical and cognitive assessment (1,3)
- collateral history is essential to establish baseline cognitive and functional status, confirm acute onset (hours to days), identify symptom fluctuation, and search for potential precipitants (1,3)
- acute changes in behaviour or alertness should be treated as a clinical vital sign prompting urgent investigation for underlying causes (3)
- caregivers may identify subtle "soft signs" prior to overt delirium (for example changes in diet, fluid intake, mobility, circadian rhythm, or mood), which require a high index of clinical suspicion (3)
Cognitive and Delirium Screening Tools
- structured brief validated screening tools are recommended across clinical settings (including community and Hospital at Home) (3):
- SQiD (Single Question in Delirium): asking an informant "Do you think [name] has been more confused lately?" (sensitivity 80%, specificity 71%) (3)
- 4AT (4 "A"s Test): rapid assessment (<2 minutes) evaluating alertness, AMT4, attention, and acute change/fluctuating course (sensitivity 88%, specificity 88%) (3)
- CAM (Confusion Assessment Method): standard 4-feature algorithm assessing acute onset/fluctuation, inattention, disorganised thinking, and altered level of consciousness (sensitivity 94%, specificity 89%) (1,3)
- alternative brief cognitive/attention tasks if time constrained:
- naming days of the week or months of the year backwards (1)
- serial sevens subtraction or digit span recitation backwards (1)
- baseline cognitive screening tools (for example IQCODE) help identify underlying pre-existing cognitive impairment (3)
Physical and Neurological Examination
- vital signs: record pulse, temperature, blood pressure, respiratory rate, and oxygen saturations to identify infection or physiological disturbance (for example hypoxia) (3)
- focused clinical examination: evaluate cardiovascular, respiratory, and abdominal systems (3)
- pain assessment: evaluate both self-reported pain and non-verbal pain signs (for example grimacing or wincing during examination) (1,3)
- search for precipitants: assess for constipation, urinary retention (for example bladder scan), dehydration, fluid overload, occult injuries, and pressure areas/wounds for infection (1,3)
- sensory impairments: check for vision or hearing loss, ensuring glasses and hearing aids are present and functional (1,3)
- neurological assessment: search for focal neurological signs, visual field changes, speech/swallowing disturbances, or meningeal signs (1,3)
Targeted Investigations
- bedside tests:
- blood glucose and blood ketones (to identify hypoglycaemia, hyperglycaemia, or ketoacidosis) (1,3)
- bladder scan (to exclude urinary retention) (3)
- electrocardiogram (ECG) (to evaluate cardiac ischaemia or arrhythmias) (3)
- urine analysis (for haematuria/proteinuria in acute kidney injury, glycosuria, or suspected UTI in non-catheterised adults aged under 65 years; routine dipstick testing is avoided in older care home residents due to high rates of asymptomatic bacteriuria) (3)
- initial laboratory tests:
- full blood count (anaemia or infection), urea and electrolytes (renal failure, hyponatraemia, or uraemia), liver function tests, serum calcium (hypercalcaemia), and C-reactive protein (inflammatory/infective response) (3)
- microbiological and virological sampling (blood cultures, wound swabs, sputum, viral respiratory panels [COVID-19, influenza, RSV], or stool testing) when infection is suspected (3)
- investigation of reversible cognitive decline triggers when underlying dementia is suspected (for example thyroid function, HbA1c, folate, and vitamin B12) (3)
- selective tests: drug levels (for example digoxin), troponin, lactate, procalcitonin, or creatine kinase (following a "long lie") (3)
- imaging tests:
- point-of-care ultrasound (POCUS) in community/home settings where available (to evaluate consolidation, pleural effusion, ascites, hydronephrosis, or deep vein thrombosis) (3)
- chest X-ray (if POCUS unavailable and infection or fluid overload suspected) (3)
- head CT: indicated for new focal neurological signs, reduced consciousness not explained by another cause, recent head injury or falls, anticoagulation therapy, or non-resolving cases of delirium without an identified cause (3)
Reference:
- Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911-922.
- NICE. Delirium: prevention, diagnosis and management in hospital and long-term care. Clinical guideline CG103. Published July 2010, last updated January 2023.
- Burton JK, Barron K, McGlen S, Jewson H, George P, Lasserson D. Community management of delirium. BMJ. 2026;395:e100817.
Related pages
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page